Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
(QDRMCFDXPIEYGX-NWRGJBOJSA-N)
Structure
- SMILES
- FC([C@@]1(C#CC2CC2)OC(=O)Nc2c1cc(Cl)cc2)(F)F.Nc1nc(=O)n(cc1F)[C@@H]1CS[C@@H](O1)CO.C[C@H](Cn1cnc2c1ncnc2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.OC(=O)/C=C/C(=O)O
- Molecular Formula:
- C45H53ClF4N9O19PS
- Molecular Weight:
- 1198.440
- Log P:
- 7.6659
- Hydrogen Bond Acceptor:
- 29
- Hydrogen Bond Donor:
- 6
- TPSA:
- 423.85
- CAS Number(s):
- 731772-50-2
Synonym(s)
1.
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2.
Atripla
External Link(s)
| MeSH | D000068257 |
| PubChem Compound | 9833525 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Immune Reconstitution Inflammatory Syndrome | FAERS: 1 | US FAERS | |
| 2 | Psoriasis | FAERS: 1 | US FAERS | |
| 3 | Acute kidney injury | 19856155 | CTD | |
| 4 | Hypercalcemia | 19856155 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.